Skip to main content
. 2021 May 6;5(5):e10462. doi: 10.1002/jbm4.10462

Fig 3.

Fig 3

The 3:1 combination therapy increases expression of both Sost and Dkk1. (A) Relative gene expression levels of (A) Sost and (B) Dkk1 in vehicle, Scl‐mAb treated (25 mg/kg), and 3:1 combination therapy–treated (25 mg/kg) mice measured at 16 weeks of age. *p < 0.05 versus vehicle, n = 6–7 mice/group.